Khan Rumana J, Gebreab Samson Y, Riestra Pia, Sims Mario, Gaye Amadou, Xu Ruihua, Davis Sharon K
Metabolic, Cardiovascular, and Inflammatory Disease Genomics Branch, Cardiovascular Section, Social Epidemiology Unit, National Human Genome Research Institute, NIH, Bethesda, MD; and
Metabolic, Cardiovascular, and Inflammatory Disease Genomics Branch, Cardiovascular Section, Social Epidemiology Unit, National Human Genome Research Institute, NIH, Bethesda, MD; and.
J Nutr. 2016 Dec;146(12):2537-2543. doi: 10.3945/jn.116.239509. Epub 2016 Oct 26.
Although it is recognized that vitamin D deficiency is associated with cardiovascular disease (CVD) risk factors, and is more common in African Americans (AAs), the pathologic mechanisms by which vitamin D may influence these risk factors are poorly understood.
We explored the association between vitamin D status, as reflected by serum 25-hydroxyvitamin D [25(OH)D] concentrations, and CVD risk factors including mean arterial pressure (MAP), fasting plasma glucose (FPG), plasma HDL cholesterol, and waist circumference (WC) in adult AAs. We also tested whether plasma C-reactive protein (CRP), adipokines (adiponectin and leptin), and aldosterone mediated the associations between 25(OH)D and these risk factors.
Data on 4010 (63.8% women; mean age: 54.0 y) individuals from the Jackson Heart Study were analyzed. Multivariable linear regression models were used to examine the associations of 25(OH)D with CVD risk factors. We used path analysis and bootstrapping methods to quantify and test the share of these associations that was statistically explained by each of the mediators by decomposing the associations into direct and indirect effects.
Serum 25(OH)D concentrations were inversely associated with WC, FPG, and MAP and were positively associated with HDL cholesterol in multivariable analysis. A nearly 20% effect of 25(OH)D on MAP was masked by aldosterone (total indirect effect: β = 0.01, P < 0.05). Approximately 23% of the effect of 25(OH)D on WC (β = -0.03, P < 0.05) and ∼9% of the effect of 25(OH)D on FPG (β = -0.02, P < 0.05) were mediated through CRP, adiponectin, and leptin together. A 23% share of the association between 25(OH)D and HDL cholesterol was mediated by adiponectin alone (β = 0.03, P < 0.05).
Our findings suggest that the associations between vitamin D status and CVD risk factors in AAs are partially mediated through circulating adipokines and CRP. More evidence, however, is required from longitudinal and randomized controlled studies to validate our findings.
尽管人们认识到维生素D缺乏与心血管疾病(CVD)风险因素相关,且在非裔美国人(AA)中更为常见,但维生素D可能影响这些风险因素的病理机制仍知之甚少。
我们探讨了血清25-羟基维生素D [25(OH)D]浓度所反映的维生素D状态与成年非裔美国人的CVD风险因素之间的关联,这些风险因素包括平均动脉压(MAP)、空腹血糖(FPG)、血浆高密度脂蛋白胆固醇和腰围(WC)。我们还测试了血浆C反应蛋白(CRP)、脂肪因子(脂联素和瘦素)和醛固酮是否介导了25(OH)D与这些风险因素之间的关联。
分析了来自杰克逊心脏研究的4010名个体(63.8%为女性;平均年龄:54.0岁)的数据。使用多变量线性回归模型来检验25(OH)D与CVD风险因素之间的关联。我们使用路径分析和自抽样方法,通过将关联分解为直接和间接效应,来量化和测试每种介导因素在统计学上对这些关联的解释比例。
在多变量分析中,血清25(OH)D浓度与WC、FPG和MAP呈负相关,与高密度脂蛋白胆固醇呈正相关。醛固酮掩盖了25(OH)D对MAP近20%的影响(总间接效应:β = 0.01,P < 0.05)。25(OH)D对WC的影响(β = -0.03,P < 0.05)中约23%以及对FPG的影响(β = -0.02,P < 0.05)中约9%是通过CRP、脂联素和瘦素共同介导的。25(OH)D与高密度脂蛋白胆固醇之间关联的23%仅由脂联素介导(β = 0.03,P < 0.05)。
我们的研究结果表明,非裔美国人中维生素D状态与CVD风险因素之间的关联部分是通过循环脂肪因子和CRP介导的。然而,需要更多来自纵向和随机对照研究的证据来验证我们的研究结果。